Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SynVaccine Logo
SynVaccine Growth Score
23
CB Rank
169469
Heat Score
59
SynVaccine develops preventive viral vaccines for various major human pathogens.
Founded
obfuscation
PrivateSeed Tel Aviv, Tel Aviv, Israel1-10 www.synvaccine.com
Biotechnology
Genetics
Health Care
Life Science
Medical
Overview

SynVaccine
Total Funding
obfuscation
Growth Score
23
Heat Score
59

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score23
-2 pts
in past quarter
Heat Score 59
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About SynVaccine

CB Rank
169469
SynVaccine develops preventive viral vaccines for various major human pathogens.
Founded
obfuscation
PrivateSeed Tel Aviv, Tel Aviv, Israel1-10 www.synvaccine.com
Biotechnology
Genetics
Health Care
Life Science
Medical

Funding Rounds

Seed
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
Yeda Research and Development Co. Ltd Logo
Yeda Research and Development Co. Ltd
Legal Name SynVaccine Limited
Also Known As Syn Vaccine
Operating Status Active
Company Type For Profit
Founders  Tuval Ben Yehezkel
About the Company
SynVaccine develops preventive viral vaccines for various major human pathogens. It owns licenses for disruptive technologies that enable the computational rational design of viral genomes and physical DNA editing of viral vaccine genome libraries. Tuval Ben Yehezkel founded SynVaccine in 2013. It has its headquarters in Tel Aviv in Israel.
Phone Number 97237684941
Contact Email info@SynVaccine.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SynRAD
A computational engine for the rational design and construction of viral-based products using synthetic biology and big data.
Immuno-Oncolytic Viruses
Synthetic viruses designed to selectively replicate in tumor cells, destroying them and inducing anti-tumor immune responses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed
obfuscation
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Sapir Venture Partners Logo
Sapir Venture Partners
No
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
—
Sapir Venture Partners Logo
Sapir Venture Partners
No
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
—
Sapir Venture Partners Logo
Sapir Venture Partners
No
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
—
Sapir Venture Partners Logo
Sapir Venture Partners
No
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
—
Sapir Venture Partners Logo
Sapir Venture Partners
No
Seed Round - SynVaccine Logo
Seed Round - SynVaccine
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

2SynVaccine is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m.

Total IP

7The intellectual property of SynVaccine includes 7 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is SynVaccine's headquarters? SynVaccine is located in Tel Aviv, Tel Aviv, Israel.Who invested in SynVaccine? SynVaccine has 2 investors including Sapir Venture Partners and  EISMEA.When was the last funding round for SynVaccine? SynVaccine closed its last funding round on
obfuscation
from a Seed round.Who are SynVaccine's competitors? Alternatives and possible competitors to SynVaccine may include Pfizer, Sanofi, and  AstraZeneca.How much funding has SynVaccine raised to date? SynVaccine has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|